BridgeBio Pharma
Price & Volume
Stats
See more52W Range | $52.75-$93.41 |
Market Cap | $12.7B |
Shares Short | 19M |
Financials
See moreRevenue (12 Mos) | $713M |
Revenue Growth (YoY) | 120.4% |
Gross Profit (12 Mos) | $673.4M |
Diluted EPS | -$3.56 |
News
See moreYahoo Finance • 2 days ago
BridgeBio reports improved symptoms in Phase 3 trial of rare-disease drug
Yahoo Finance • last month
BridgeBio Pharma (BBIO) Down 10.7% Since Last Earnings Report: Can It Rebound?
Yahoo Finance • last month
4 Rare Disease Drugmakers With Strong Long-Term Growth Prospects
Yahoo Finance • last month
AM Markets Need to Know: Nasdaq rebounds in August, Anthropic expands AI capacity, and more
About
CEO | Dr. Neil Kumar Ph.D. |
CFO | Dr. Thomas Trimarchi Ph.D. |
Address | 3160 Porter Drive, Palo Alto, CA, United States, 94304 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 999 |